A role for glia in the progression of Rett-syndrome

Nature

Volumn 475, Issue 7357, 2011, Pages 497-500

  Lioy, Daniel T ^a,b   Garg, Saurabh K ^a,b   Monaghan, Caitlin E ^a,b   Raber, Jacob ^a,c   Foust, Kevin D ^d   Kaspar, Brian K ^d   Hirrlinger, Petra G ^e   Kirchhoff, Frank ^f,g   Bissonnette, John M ^a,h   Ballas, Nurit ⁱ   Mandel, Gail ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Paul Flechsig Inst for Brain Res   (Germany)

^f MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^g SAARLAND UNIVERSITY   (Germany)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; TAMOXIFEN; VESICULAR GLUTAMATE TRANSPORTER 1;

CHROMOSOME; GENE EXPRESSION; HERITABILITY; LOCOMOTION; NERVOUS SYSTEM DISORDER; NEUROLOGY; PROTEIN; RODENT; SYMPTOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIA; LIFESPAN; LOCOMOTION; MALE; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; RETT SYNDROME;

ANIMALS; ANXIETY; ASTROCYTES; BEHAVIOR, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROGLIA; NEURONS; RETT SYNDROME; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

MUS;

EID: 79960907896     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10214     Document Type: Article

References (29)

1. Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437 (2007). (Pubitemid 350026269)
2. Shahbazian, M. D., Antalffy, B., Armstrong, D. L. & Zoghbi, H. Y. Insight into Rett syndrome:MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115 (2002).
3. Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptomsthatmimic Rett syndrome. NatureGenet. 27, 322-326 (2001). (Pubitemid 32201856)
4. Chen, R. Z., Akbarian, S., Tudor, M.&Jaenisch, R. Deficiency ofmethyl-CpGbinding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genet. 27, 327-331 (2001). (Pubitemid 32201857)
5. Kishi, N. & Macklis, J. D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronalmaturation rather than cell fate decisions.Mol. Cell. Neurosci. 27, 306-321 (2004). (Pubitemid 39433843)
6. McGill, B. E. et al. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 103, 18267-18272 (2006). (Pubitemid 44871647)
7. Fyffe, S. L. et al. DeletionofMecp2in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59, 947-958 (2008).
8. Samaco, R. C. et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl Acad. Sci. USA 106, 21966-21971 (2009).
9. Luikenhuis, S., Giacometti, E., Beard, C. F. & Jaenisch, R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA 101, 6033-6038 (2004). (Pubitemid 38520523)
10. Chao, H. T. et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263-269 (2010).
11. Ballas, N., Lioy, D. T., Grunseich, C. & Mandel, G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nature Neurosci. 12, 311-317 (2009).
12. Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J. M. & Jin, L. W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through Gap junctions. J. Neurosci. 29, 5051-5061 (2009).
13. Maezawa, I. & Jin, L. W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 5346-5356 (2010).
14. Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (2007). (Pubitemid 46328028)
15. Hirrlinger, P. G., Scheller, A., Braun, C., Hirrlinger, J.&Kirchhoff, F. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifeninducible DNA recombinase variant CreERT2. Glia 54, 11-20 (2006). (Pubitemid 43980030)
16. Brenner, M., Kisseberth, W. C., Su, Y., Besnard, F. & Messing, A. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14, 1030-1037 (1994). (Pubitemid 24081901)
17. Chow, L., Zhang, J. & Baker, S. J. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen- inducibleDNA recombinase variant CreERT2. Transgenic Res. 17, 919-928 (2008).
18. Casper, K. B., Jones, K. & McCarthy, K. D. Characterization of astrocyte-specific conditional knockouts. Genesis 45, 292-299 (2007). (Pubitemid 46842894)
19. Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature Biotechnol. 27, 59-65 (2008).
20. Stearns, N. A. et al. Behavioral and anatomical abnormalities in Mecp2 mutant mice: A model for Rett syndrome. Neuroscience 146, 907-921 (2007). (Pubitemid 46694130)
21. Pelka, G. J. et al. Brain Mecp2 deficiency is associated with learning and cognitive deficits andalteredgene activity in the hippocampal regionofmice.129,887-898 (2006).
22. Weese-Mayer, D. E. et al. Autonomic nervous systemdysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res. 60, 443-449 (2006). (Pubitemid 44427598)
23. Viemari, J. et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci. 25, 11521-11530 (2005). (Pubitemid 43098445)
24. Bauman, M. L., Kemper, T. L. & Arin, D. M. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 45, 1581-1586 (1995).
25. Armstrong, D. D. Neuropathology of Rett syndrome. J. Child Neurol. 20, 747-753 (2005). (Pubitemid 41498709)
26. Chao, H. T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58-65 (2007). (Pubitemid 47484176)
27. Marchetto, M. L. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539 (2010).
28. Ilieva, H., Polymenidou, M. & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772 (2009).
29. Gemelli, T. et al. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychol. 59, 468-476 (2006). (Pubitemid 43289228)